Nasopharyngeal Carcinoma
📧 Sign up to get email alerts when something new happens for Nasopharyngeal Carcinoma.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS trial_result · 2023-05-26Clinical Trial Update: Reduced-target Resection After Induction Chemotherapy in Resectable Recurrent Nasopharyngeal Carcinoma [Phase 3]
A Phase 3 clinical trial evaluating reduced-target resection after induction chemotherapy in resectable recurrent nasopharyngeal carcinoma i…
-
CLINICAL_TRIALS trial_result · 2023-05-22Clinical Trial Update: TPF+CCRT vs.CCRT+PF in High Risk Nasopharyngeal Carcinoma [Phase 3]
A Phase 3 trial comparing TPF+CCRT versus CCRT+PF for high-risk nasopharyngeal carcinoma is active but not currently recruiting.
-
CLINICAL_TRIALS trial_result · 2023-05-22Clinical Trial Update: Phase Ⅲ Trial of Adjuvant Chemotherapy in Patients With N2-3 Nasopharyngeal Carcinoma [Phase 3]
Phase III trial update for adjuvant chemotherapy in nasopharyngeal carcinoma (N2-3) is in progress with unknown status.
-
CLINICAL_TRIALS trial_result · 2023-05-11Clinical Trial Update: Gemcitabine and Camrelizumab Plus Apatinib Versus Cisplatin in First-line Treatment of RM-NPC [Phase 3]
Phase 3 trial comparing gemcitabine and camrelizumab plus apatinib vs cisplatin as first-line therapy for nasopharyngeal carcinoma is ongoin…
-
CLINICAL_TRIALS trial_result · 2023-05-06Clinical Trial Update: Apatinib and Camrelizumab in Recurrent or Metastatic Nasopharyngeal Carcinoma With First-line Treatment Failure [Phase 2]
Phase 2 trial evaluating apatinib combined with camrelizumab in recurrent or metastatic nasopharyngeal carcinoma after first-line treatment …
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS trial_result · 2023-05-03Clinical Trial Update: Induction Chemotherapy Followed by IMRT or Concurrent Chemoradiotherapy in Locoregionally Advanced Nasopharyngeal Carcinoma [Phase 3]
Phase 3 trial evaluating induction chemotherapy followed by IMRT versus concurrent chemoradiotherapy in locoregionally advanced nasopharynge…
-
CLINICAL_TRIALS trial_result · 2023-04-13Clinical Trial Update: PD-1 Combined With Intensity Modulated Radiation Therapy in the Treatment of Intermediate-risk Nasopharyngeal Carcinoma [Phase 2]
Phase 2 trial evaluating PD-1 blockade combined with intensity-modulated radiation therapy for intermediate-risk nasopharyngeal carcinoma; c…
-
CLINICAL_TRIALS trial_result · 2023-04-12Clinical Trial Update: TPC vs PF as Induction Chemotherapy Combined With CCRT for Stage IVa-b Nasopharyngeal Carcinoma [Phase 3]
Phase 3 trial comparing TPC versus PF as induction chemotherapy combined with concurrent chemoradiotherapy for stage IVa-b nasopharyngeal ca…
-
CLINICAL_TRIALS trial_result · 2023-03-30Clinical Trial Update: Cadonilimab (AK104) in the Treatment of Nasopharyngeal Carcinoma [Phase 2]
Phase 2 clinical trial update for Cadonilimab (AK104) in nasopharyngeal carcinoma; status not reported in the provided snippet.
-
CLINICAL_TRIALS trial_result · 2023-03-23Clinical Trial Update: Camrelizumab for the Treatment of Locally Advanced Nasopharyngeal Carcinoma [Phase 2]
Phase 2 clinical trial update evaluating camrelizumab for locally advanced nasopharyngeal carcinoma.
-
CLINICAL_TRIALS trial_result · 2023-03-22Clinical Trial Update: A Multi-center, Randomized, Double-blind, Phase III Clinical Trial of Leucogen Versus Placebo on Leukocyte and Platelet Whole-course Management Assisted by PFLL Chemotherapy in the Treatment of Stage IV, Recurrent or Metastatic NPC [Phase 3]
A Phase 3 randomized trial comparing Leucogen to placebo for management of leukocyte and platelet counts during PFLL chemotherapy in stage I…
-
CLINICAL_TRIALS trial_result · 2023-03-16Clinical Trial Update: Intensified Treatments for Patients With Locally Advanced Nasopharyngeal Carcinoma With Detectable EBV DNA After One Cycle GP Regime Neoadjuvant Chemotherapy [Phase 3]
A Phase 3 trial evaluating intensified treatments for locally advanced nasopharyngeal carcinoma with detectable EBV DNA after one cycle of G…
-
CLINICAL_TRIALS trial_result · 2023-02-23Clinical Trial Update: Efficacy and Safety of Sintilimab Plus Bevacizumab in Metastatic Nasopharyngeal Carcinoma After Failure of Platinum-based Chemotherapy: An Open-label Phase II Study [Phase 2]
Phase II open-label study evaluating the efficacy and safety of sintilimab plus bevacizumab in patients with metastatic nasopharyngeal carci…
-
CLINICAL_TRIALS trial_result · 2023-02-13Clinical Trial Update: CDK4/6 Inhibitor Plus Camrelizumab for PD-1 Inhibitor Refractory R/M NPC [Phase 2]
Phase 2 clinical trial evaluating a CDK4/6 inhibitor in combination with camrelizumab for PD-1 inhibitor-refractory recurrent/metastatic nas…
-
CLINICAL_TRIALS trial_result · 2023-02-08Clinical Trial Update: Clinical Study of Mitoxantrone Hydrochloride Liposome Injection Combined With Capecitabine Versus Capecitabine Monotherapy in Patients With Recurrent Metastatic Nasopharyngeal Carcinoma Who Failed Platinum-containing Treatment [Phase 3]
Phase 3 trial evaluating mitoxantrone hydrochloride liposome injection plus capecitabine versus capecitabine alone in recurrent metastatic n…
-
CLINICAL_TRIALS trial_result · 2023-02-08Clinical Trial Update: Targeted or Chemotherapy Combined With Immunotherapy Versus Chemotherapy for PD-1 Inhibitor Refractory R/M NPC [Phase 2]
Phase 2 trial evaluating targeted or chemotherapy combined with immunotherapy versus chemotherapy for PD-1 inhibitor-refractory recurrent/me…
-
CLINICAL_TRIALS trial_result · 2023-02-06Clinical Trial Update: Toripalimab and Gemcitabine in Recurrent or Metastatic Nasopharyngeal Carcinoma. [Phase 2]
Phase 2 clinical trial evaluating toripalimab in combination with gemcitabine for recurrent or metastatic nasopharyngeal carcinoma.
-
CLINICAL_TRIALS trial_result · 2023-01-31Clinical Trial Update: Effect of Standard Nutrition Therapy on Nutritional Status and Prognosis in Locoregionally Advanced Nasopharyngeal Carcinoma Patients With Malnutrition [Phase 3]
Phase 3 trial evaluating the impact of standard nutrition therapy on nutritional status and prognosis in locoregionally advanced nasopharyng…
-
CLINICAL_TRIALS trial_result · 2023-01-13Clinical Trial Update: Apatinib Combined With PD-1 in the Treatment of Recurrent or Metastatic Nasopharyngeal Carcinoma [Phase 2]
A phase 2 clinical trial evaluating apatinib in combination with PD-1 inhibitor for recurrent or metastatic nasopharyngeal carcinoma has com…
-
CLINICAL_TRIALS trial_result · 2023-01-10Clinical Trial Update: Radiotherapy Alone Versus Concurrent Chemo-radiotherapy for Nasopharyngeal Carcincoma Patients With Undectable EBV DNA After One Cylce Neoadjuvant Chemotherpy [Phase 3]
A Phase 3 clinical trial comparing radiotherapy alone to concurrent chemoradiotherapy in nasopharyngeal carcinoma patients with detectable d…
-
CLINICAL_TRIALS trial_result · 2022-11-07Clinical Trial Update: Radiotherapy Plus Concurrent Nimotuzumab or Cisplatin in Stage II-III Nasopharyngeal Carcinoma [Phase 3]
Phase 3 trial evaluating radiotherapy with either nimotuzumab or cisplatin concurrently for stage II-III nasopharyngeal carcinoma; status no…
-
CLINICAL_TRIALS trial_result · 2022-10-28Clinical Trial Update: Maintenance Capecitabine Plus Best Supportive Care Versus Best Supportive Care for Metastatic Nasopharyngeal Carcinoma [Phase 3]
Phase 3 trial assessing maintenance capecitabine plus best supportive care versus best supportive care alone in metastatic nasopharyngeal ca…
-
CLINICAL_TRIALS trial_result · 2022-09-27Clinical Trial Update: Optimization of Cervical Nodal CTV for Early and Medium Stage NPC [Phase 3]
Phase 3 clinical trial update focusing on optimizing cervical nodal clinical target volume for early and medium stage nasopharyngeal carcino…
-
CLINICAL_TRIALS trial_result · 2022-09-19Clinical Trial Update: Elective Level Ib Irradiation in Nasopharyngeal Carcinoma Patients Based on the International Guidelines [Phase 3]
Phase 3 trial investigating elective level Ib irradiation in nasopharyngeal carcinoma following international guidelines.
-
CLINICAL_TRIALS trial_result · 2022-08-31Clinical Trial Update: Concurrent Cisplatin Chemoradiation With or Without Capecitabine as Adjuvant Chemotherapy in Local Advanced High Risk Nasopharyngeal Carcinoma: Randomized Control Clinical Trial [Phase 3]
Phase 3 randomized trial evaluating concurrent cisplatin chemoradiation with or without capecitabine as adjuvant therapy for local advanced …